News & Perspective

Apr 03, 2019

Apr 03, 2019
Community Ebola representatives in DR Congo

DRC Ebola total hits 1,100; study targets secondary spread

Admission to an Ebola treatment unit was tied to a 38% drop in secondary cases.

Apr 03, 2019

News Scan for Apr 03, 2019

Ebola Bombali in Kenyan bats
Universal flu vaccine trial
E coli O103 in 4 states
Lassa fever in Nigeria
Waterborne hospital infections

Feb 12, 2019

Feb 12, 2019

News Scan for Feb 12, 2019

More Saudi MERS cases
Yellow fever in Brazil
Lassa fever in Guinea and Nigeria
Zika in Mexico
Gain-of-function H5N1 studies to resume

Jan 29, 2019

Jan 29, 2019
DR Congo women

Katwa remains outbreak hot spot as Ebola cases reach 743

Four of the 7 new cases were reported in Katwa, the latest outbreak hot spot.

Dec 13, 2018

Dec 13, 2018
Ebola baby

Officials note 10 new Ebola cases as youngest patient recovers

Also, the NIAID has reached an agreement to license an experimental treatment.

Oct 30, 2018

Oct 30, 2018
ebola vaccine

Ebola total hits 276 as lasting effect noted for 3 vaccines

Immune response lasted 2.5 years for the vaccines, the longest yet in ongoing studies of Ebola immunization.

Oct 18, 2018

Oct 18, 2018

News Scan for Oct 18, 2018

Lassa spread in Nigeria
US arbovirus trends
Identifying infection prevention gaps

Aug 16, 2018

Aug 16, 2018
vaccine research

CEPI announces new collaboration and funding for Lassa vaccine

The announcement comes as Nigeria is experiencing its largest outbreak, with 481 confirmed cases reported as of last week, 133 of them fatal.

Jan 10, 2018

Jan 10, 2018

News Scan for Jan 10, 2018

Ebola antibody findings
USDA egg product rule
1918 pandemic flu severity

Oct 11, 2017

Oct 11, 2017
Ebola vaccine study

Liberia trial finds Ebola vaccines yield year-long immune response

A trial at the end of Liberia's Ebola outbreak shows 2 candidate vaccines posed no major safety concerns and triggered immune responses that lasted at least a year.

Pages

by Topic

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»